Mingzhe Weng

2.8k total citations · 1 hit paper
46 papers, 2.0k citations indexed

About

Mingzhe Weng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Mingzhe Weng has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 25 papers in Cancer Research and 18 papers in Surgery. Recurrent topics in Mingzhe Weng's work include Cancer-related molecular mechanisms research (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Circular RNAs in diseases (13 papers). Mingzhe Weng is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Circular RNAs in diseases (13 papers). Mingzhe Weng collaborates with scholars based in China, Canada and United States. Mingzhe Weng's co-authors include Zhiwei Quan, Mingdi Zhang, Di Zhou, Wei Gong, Mingzhe Ma, Xiaocai Wu, Qiang Cai, Yiyu Qin, Shou-Hua Wang and Mingzhe Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Mingzhe Weng

46 papers receiving 2.0k citations

Hit Papers

Hypoxia inducible lncRNA-CBSLR modulates ferroptosis thro... 2021 2026 2022 2024 2021 50 100 150

Peers

Mingzhe Weng
Yiren Hu China
Qian Xu China
Jane J. Sohn United States
Mingzhe Weng
Citations per year, relative to Mingzhe Weng Mingzhe Weng (= 1×) peers Dianzhong Luo

Countries citing papers authored by Mingzhe Weng

Since Specialization
Citations

This map shows the geographic impact of Mingzhe Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzhe Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzhe Weng more than expected).

Fields of papers citing papers by Mingzhe Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingzhe Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzhe Weng. The network helps show where Mingzhe Weng may publish in the future.

Co-authorship network of co-authors of Mingzhe Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Mingzhe Weng. A scholar is included among the top collaborators of Mingzhe Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzhe Weng. Mingzhe Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Hong, Kun Liu, Jinqiu Fu, et al.. (2025). Establishment of ABEI-based direct chemiluminescence immunoassays for PIC, TAT, tPAIC, and TM and their preliminary evaluation in thrombotic diseases. Analytical Methods. 17(26). 5489–5497. 1 indexed citations
2.
Weng, Hao, Jun Gu, Mingzhe Weng, et al.. (2024). Efficacy and long-term outcomes of single-balloon enteroscopy-assisted treatment for biliary obstruction after choledochojejunostomy. Surgical Endoscopy. 38(11). 6282–6293. 2 indexed citations
3.
Weng, Hao, Xiaoling Song, Yijun Shu, et al.. (2023). Preoperative pancreatic CT value is related to pancreatic fistula after pancreaticoduodenectomy: a retrospective study. Gland Surgery. 12(2). 243–251. 1 indexed citations
5.
Weng, Mingzhe, et al.. (2021). Utility of endoscopic retrograde cholangiopancreatography in infant patients with conservational endoscopy. Translational Pediatrics. 10(10). 2506–2513. 10 indexed citations
6.
Cai, Qiang, Shouhua Wang, Longyang Jin, et al.. (2019). Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Molecular Cancer. 18(1). 82–82. 147 indexed citations
7.
Ma, Mingzhe, Yan Zhang, Mingzhe Weng, et al.. (2016). Long Noncoding RNA GCASPC , a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase–Dependent Cell Proliferation in Gallbladder Cancer. Cancer Research. 76(18). 5361–5371. 77 indexed citations
8.
Zhang, Hongchen, Zhizhen Li, Bingfeng Chu, et al.. (2016). Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma. Tumor Biology. 37(6). 8305–8315. 12 indexed citations
9.
Wang, Shou-Hua, Xiaocai Wu, Mingdi Zhang, et al.. (2016). Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2. Tumor Biology. 37(7). 9721–9730. 70 indexed citations
10.
Ma, Mingzhe, Mingzhe Weng, Mingdi Zhang, et al.. (2015). Targeting gallbladder cancer: hyaluronan sensitizes cancer cells to chemo-therapeutics.. PubMed. 8(2). 1822–5. 5 indexed citations
11.
Ma, Mingzhe, Xiang Kong, Mingzhe Weng, et al.. (2014). Long non‐coding RNA‐LET is a positive prognostic factor and exhibits tumor‐suppressive activity in gallbladder cancer. Molecular Carcinogenesis. 54(11). 1397–1406. 60 indexed citations
12.
Weng, Mingzhe, Mingdi Zhang, Yiyu Qin, et al.. (2014). Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virus. Chinese Medical Journal. 127(12). 2350–2356. 10 indexed citations
13.
Weng, Mingzhe, Fangbin Song, Jinyu Chen, et al.. (2014). The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells. Tumor Biology. 36(2). 959–966. 20 indexed citations
14.
Weng, Mingzhe, Wei Gong, Mingzhe Ma, et al.. (2014). Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo. Molecular Cancer. 13(1). 82–82. 22 indexed citations
15.
Weng, Mingzhe, Peng–Yuan Zhuang, Pei‐Yi Lin, et al.. (2014). ZBTB20 is involved in liver regeneration after partial hepatectomy in mouse. Hepatobiliary & pancreatic diseases international. 13(1). 48–54. 11 indexed citations
16.
Kong, Xiang, Mingzhe Ma, Yan Zhang, et al.. (2014). Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma. BMC Complementary and Alternative Medicine. 14(1). 254–254. 30 indexed citations
17.
Zhou, Di, Jiandong Wang, Mingzhe Weng, et al.. (2012). Infections of Helicobacter spp. in the biliary system are associated with biliary tract cancer. European Journal of Gastroenterology & Hepatology. 25(4). 447–454. 53 indexed citations
18.
Weng, Mingzhe, Yong Zhang, Yong Yang, et al.. (2012). Radiofrequency Ablation versus Resection for Colorectal Cancer Liver Metastases: A Meta-Analysis. PLoS ONE. 7(9). e45493–e45493. 55 indexed citations
19.
Weng, Mingzhe, et al.. (2011). Indoleamine 2,3-Dioxygenase as a Predictor of Acute Rejection After Orthotopic Liver Transplantation in Rat Model. Transplantation Proceedings. 43(10). 3969–3972. 7 indexed citations
20.
Weng, Mingzhe, et al.. (2011). The hepatic protective mechanism of Ginkgo biloba extract in rats with obstructive jaundice. SHILAP Revista de lepidopterología. 11(4). 209–213. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026